Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “derivative”

1,342 pharma patents match "derivative" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,342
Index total 30,257
Page 11 / 56

Quick answer

This filtered view shows 1,342 pharmaceutical patents matching "derivative" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,342 results for “derivative” · 30,257 patents in full index Clear search

  1. US 10766903

    Piperidine derivatives as inhibitors of ubiquitin specific protease 7

    ALMAC DISCOVERY LIMITED · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  2. US 10766864

    Morphinan derivatives for the treatment of neuropathic pain

    Nektar Therapeutics · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  3. US 10759793

    2-(pyrazolopyridin-3-yl)pyrimidine derivatives as JAK inhibitors

    Almirall, S.A. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  4. US 10759812

    Thienopyrimidine derivative and use thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  5. US 10758530

    Carboxamide derivatives useful as rsk inhibitors

    PHOENIX MOLECULAR DESIGNS · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  6. US 10752581

    4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

    The Regents of the University of California Santa · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  7. US 10752598

    Aryldiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  8. US 10745397

    1-Substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as EP4 receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  9. US 10745413

    Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives

    Verrica Pharmaceuticals Inc. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  10. US 10730882

    2-aminoquinazoline derivatives as P70S6 kinase inhibitors

    SENTINEL ONCOLOGY LIMITED · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  11. US 10709790

    Chemical conjugates of Evans Blue derivatives and their use in the production of long-acting therapeutics

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  12. US 10703721

    Caffeic acid derivatives and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted
  13. US 10703735

    4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer

    Lead Discovery Center GmbH · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted
  14. US 10703701

    Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

    PTC THERAPEUTICS, INC. · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted
  15. US 10702525

    Pyrimidine derivatives as anti-diabetic agents

    UNITED ARAB EMIRATES UNIVERSITY · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted
  16. US 10702628

    Hyaluronic acid derivative and neural stem cells for SCI and PNT regeneration

    Anika Therapeutics S.r.l. · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted
  17. US 10696631

    Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted
  18. US 10696713

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted
  19. US 10696693

    Fused imidazole derivatives as TGF-beta inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted
  20. US 10689347

    Substituted heterocyclyl derivatives as CDK inhibitors

    Aurigene Discovery Technologies Limited · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  21. US 10683277

    Triazole derivatives as P2Y14 receptor antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted
  22. US 10676442

    Salt derivative of tetrahydroisoquinoline and crystalline thereof and preparation method therefore and application thereof

    China State Institute of Pharmaceutical Industry · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  23. US 10675271

    Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy

    Monopar Therapeutics Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  24. US 10676474

    1,6-naphthyridine derivatives as CDK4/6 inhibitor

    Medshine Discovery Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted